From molecular crosstalk to precision therapy: targeting ferroptosis and cuproptosis in oral squamous cell carcinoma - Scorecard - MDSpire

From molecular crosstalk to precision therapy: targeting ferroptosis and cuproptosis in oral squamous cell carcinoma

  • By

  • Xikun Ma

  • Yiqi Chen

  • Huaqing Mai

  • Pengyu Lai

  • Adili Alimujiang

  • Mingxing Lu

  • April 30, 2026

  • 0 min

Share

Clinical Scorecard: Advancing Precision Treatment: Targeting Ferroptosis and Cuproptosis in Oral Squamous Cell Carcinoma through Molecular Interactions

At a Glance

CategoryDetail
Condition
Key MechanismsFerroptosis and cuproptosis as novel programmed cell death modalities impacting tumor metabolism, immune evasion, and therapeutic resistance in OSCC.
Target Population
Care Setting

Key Highlights

  • Combination strategies targeting both ferroptosis and cuproptosis are emerging, potentially improving treatment outcomes.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • Regular assessment of treatment response and side effects, including specific biomarkers and imaging techniques.

      Risks

        Patient & Prescribing Data

        Targeting ferroptosis and cuproptosis may enhance therapeutic efficacy and reduce resistance, potentially integrated into existing treatment protocols.

        Clinical Best Practices

        • Integrate molecular mechanisms of ferroptosis and cuproptosis into treatment planning, supported by recent studies.

        References

        Original Source(s)

        Related Content